InterCure Subsidiary Canndoc Files Confidential Nasdaq Prospectus
InterCure, chaired by former Israeli prime minister Ehud Barak, has previously announced its IPO intentions. Cannadoc is one of nine licensed cannabis growers in Israel
Tzally Greenberg | 15:07 15.04.2019
Israeli cannabis cultivator Canndoc Ltd. has submitted a confidential prospectus for a Nasdaq initial public offering, parent company InterCure Ltd. announced in a Tel Aviv Stock Exchange filing Monday. The company intends to list 15%-20% of its shares, according to one person familiar with the matter who spoke with Calcalist on condition of anonymity.